About Event

Welcome to the 4th Operationalize Decentralized Clinical Trials Summit

100+ DCT leaders gathered to hear exclusive case studies and engage in open discussions offering practical, implementable, and grounded insights. Each and every session offered key take-homes and an opportunity to examine different strategies from the perspectives of pharma, CROs, clinical trial sites, pharmacies, and patient advocacy groups.

All presenters shared real-life case studies that covered both successes and failures, this forum encouraged in-depth discussions on key topics such as:

  • Innovating new approaches to start-up DCTs
  • Vetting vendors amongst an immature company landscape
  • Driving DE&I into patient recruitment to meet regulatory requirements
  • Understanding what success looks like across stakeholders
  • Utilizing the patient experience to inform DCT planning

Learn how to design and execute decentralized clinical trials in complex disease indications by overcoming pitfalls in patient recruitment, technology integration and vendor management by listening to real world case studies from Bayer and Boehringer Ingelheim


Understand what a successful decentralized clinical trial looks like from the patient and trial site perspective to reconsider your approach to planning and delivery to ensure engagement across stakeholders with the Savvy Cooperative, HCA Healthcare and The Leukemia & Lymphoma Society


Streamline your patient recruitment strategy by learning to overcome the limitations with recruiting from rural populations and understanding how to plan for DE&I to ensure you meet new regulatory requirements with the Novartis Institutes for BioMedical Research and Massive Bio


Gain insights into the current state of play of decentralized clinical research to
understand how to sustain momentum, overcome the risk aversive mindset of the
pharmaceutical industry and how to leverage retail pharmacies in your DCTs with the
DTRA, CVS Health and GSK


Implement approaches to gather insights on the patient burden and utilize their experience to inform stakeholders and make DCTs truly more patient-centric with Praxis Precision Medicines and Merck